Cannabis mixtures studied as treatment for COVID inflammation

MJBizDaily
By Pamela MooreFeb 18, 2021, 2:35 pm210 pts
Working with GB Sciences, the Las Vegas-based R&D arm of the Canadian company GBS Global Biopharma, Michigan State University (MSU) professor Norbert Kaminski is using proprietary cannabinoid-containing complex mixtures (CCCM) in an attempt to treat Cytokine Release Syndrome (CRS) and associated conditions such…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

SQDC announces extended hours for several retail locations 69

Medical Cannabis Patients Aren't Celebrating 64

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.